Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Pasireotide in Prevention of GI Toxicity

NCT02215070

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +22 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation

NCT00375219

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Teva Investigational Site 003 Los Angeles, California, United States
  • Teva Investigational Site 007 Jacksonville, Florida, United States
  • Teva Investigational Site 006 Atlanta, Georgia, United States
  • Teva Investigational Site 008 Beech Grove, Indiana, United States
View all 32 locations
View Trial Details
Completed

European Stop Tyrosine Kinase Inhibitor Study

NCT01596114

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Fakultní nemocnice Brno, Czechia
  • Fakultní nemocnice Hradec Králové Hradec Králové, Czechia
  • University Hospital Olomouc Olomouc, Czechia
  • University Hospital Plzen Pilsen, Czechia
View all 50 locations
View Trial Details
Completed

Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)

NCT00412360

Conditions
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +24 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Childrens Hospital at Oakland Oakland, California, United States
View all 38 locations
View Trial Details
Completed

Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor

NCT02426086

Conditions
Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +7 more
Locations
  • Birmingham, Alabama, United States
  • Duarte, California, United States
  • La Jolla, California, United States
  • Los Angeles, California, United States
View all 72 locations
View Trial Details

Related conditions